{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:15:45Z","timestamp":1743394545349,"version":"3.40.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00059-024-05291-w","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T14:52:00Z","timestamp":1736866320000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impfungen bei kardiovaskul\u00e4ren Erkrankungen","Vaccination and cardiovascular diseases"],"prefix":"10.1007","volume":"50","author":[{"given":"Markus","family":"Therre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mert","family":"Tokcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Markwirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"5291_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/oxfordjournals.aje.a112007","volume":"100","author":"J Housworth","year":"1974","unstructured":"Housworth\u00a0J, Langmuir\u00a0AD (1974) Excess mortality from epidemic influenza, 1957\u20131966. Am J Epidemiol 100:40\u201348. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a112007","journal-title":"Am J Epidemiol"},{"key":"5291_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa1702090","volume":"378","author":"JC Kwong","year":"2018","unstructured":"Kwong\u00a0JC, Schwartz\u00a0KL, Campitelli\u00a0MA et\u00a0al (2018) Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N\u00a0Engl J Med 378:345\u2013353. https:\/\/doi.org\/10.1056\/NEJMoa1702090","journal-title":"N Engl J Med"},{"key":"5291_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/s0140-6736(97)11084-4","volume":"351","author":"CR Meier","year":"1998","unstructured":"Meier\u00a0CR, Jick\u00a0SS, Derby\u00a0LE et\u00a0al (1998) Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet Lond Engl 351:1467\u20131471. https:\/\/doi.org\/10.1016\/s0140-6736(97)11084-4","journal-title":"Lancet Lond Engl"},{"key":"5291_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1469-0691.2010.03296.x","volume":"17","author":"AHW Bruns","year":"2011","unstructured":"Bruns\u00a0AHW, Oosterheert\u00a0JJ, Cucciolillo\u00a0MC et\u00a0al (2011) Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. Clin Microbiol Infect 17:763\u2013768. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03296.x","journal-title":"Clin Microbiol Infect"},{"key":"5291_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1183\/09031936.00049111","volume":"39","author":"A Singanayagam","year":"2012","unstructured":"Singanayagam\u00a0A, Singanayagam\u00a0A, Elder\u00a0DHJ, Chalmers\u00a0JD (2012) Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Eur Respir\u00a0J 39:187\u2013196. https:\/\/doi.org\/10.1183\/09031936.00049111","journal-title":"Eur Respir J"},{"key":"5291_CR6","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.3390\/jcm12072577","volume":"12","author":"ED Meregildo-Rodriguez","year":"2023","unstructured":"Meregildo-Rodriguez\u00a0ED, Asmat-Rubio\u00a0MG, Rojas-Benites\u00a0MJ, V\u00e1squez-Tirado\u00a0GA (2023) Acute Coronary Syndrome, Stroke, and Mortality after Community-Acquired Pneumonia: Systematic Review and Meta-Analysis. J\u00a0Clin Med 12:2577. https:\/\/doi.org\/10.3390\/jcm12072577","journal-title":"J Clin Med"},{"key":"5291_CR7","doi-asserted-by":"publisher","first-page":"570681","DOI":"10.3389\/fimmu.2020.570681","volume":"11","author":"R Gopal","year":"2020","unstructured":"Gopal\u00a0R, Marinelli\u00a0MA, Alcorn\u00a0JF (2020) Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection. Front Immunol 11:570681. https:\/\/doi.org\/10.3389\/fimmu.2020.570681","journal-title":"Front Immunol"},{"key":"5291_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/eurjpc\/zwae016","volume":"31","author":"J Rademacher","year":"2024","unstructured":"Rademacher\u00a0J, Therre\u00a0M, Hinze\u00a0CA et\u00a0al (2024) Association of respiratory infections and the impact of vaccinations on cardiovascular diseases. Eur J Prev Cardiol 31:877\u2013888. https:\/\/doi.org\/10.1093\/eurjpc\/zwae016","journal-title":"Eur J Prev Cardiol"},{"key":"5291_CR9","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s100960000376","volume":"19","author":"CR Meier","year":"2000","unstructured":"Meier\u00a0CR, Napalkov\u00a0PN, Wegm\u00fcller\u00a0Y et\u00a0al (2000) Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 19:834\u2013842. https:\/\/doi.org\/10.1007\/s100960000376","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5291_CR10","doi-asserted-by":"publisher","first-page":"9696","DOI":"10.1038\/s41598-021-89038-1","volume":"11","author":"J Kim","year":"2021","unstructured":"Kim\u00a0J, Park\u00a0SJ, Choi\u00a0S et\u00a0al (2021) Hospitalization for acute coronary syndrome increases the long-term risk of pneumonia: a\u00a0population-based cohort study. Sci Rep 11:9696. https:\/\/doi.org\/10.1038\/s41598-021-89038-1","journal-title":"Sci Rep"},{"key":"5291_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25646\/12311","volume":"31","author":"St\u00e4ndige Impfkommission (STIKO) beim Robert Koch-Institut:","year":"2024","unstructured":"St\u00e4ndige Impfkommission (STIKO) beim Robert Koch-Institut: (2024) Stellungnahme der STIKO zur Anwendung des 20-valenten Pneumokokken-Konjugatimpfstoffs (PCV20) im S\u00e4uglings\u2011, Kindes- und Jugendalter. Epid Bull 31:3\u20138. https:\/\/doi.org\/10.25646\/12311","journal-title":"Epid Bull"},{"key":"5291_CR12","doi-asserted-by":"publisher","first-page":"CD001269","DOI":"10.1002\/14651858.CD001269.pub6","volume":"2","author":"V Demicheli","year":"2018","unstructured":"Demicheli\u00a0V, Jefferson\u00a0T, Ferroni\u00a0E et\u00a0al (2018) Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2:CD1269. https:\/\/doi.org\/10.1002\/14651858.CD001269.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"5291_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1183\/09031936.00190008","volume":"34","author":"RHH Groenwold","year":"2009","unstructured":"Groenwold\u00a0RHH, Hoes\u00a0AW, Hak\u00a0E (2009) Impact of influenza vaccination on mortality risk among the elderly. Eur Respir\u00a0J 34:56\u201362. https:\/\/doi.org\/10.1183\/09031936.00190008","journal-title":"Eur Respir J"},{"key":"5291_CR14","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s11886-022-01748-8","volume":"24","author":"YM Maniar","year":"2022","unstructured":"Maniar\u00a0YM, Al-Abdouh\u00a0A, Michos\u00a0ED (2022) Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis. Curr Cardiol Rep 24:1327\u20131335. https:\/\/doi.org\/10.1007\/s11886-022-01748-8","journal-title":"Curr Cardiol Rep"},{"key":"5291_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/eurheartj\/ehac737","volume":"44","author":"JA Davidson","year":"2023","unstructured":"Davidson\u00a0JA, Banerjee\u00a0A, Douglas\u00a0I et\u00a0al (2023) Primary prevention of acute cardiovascular events by influenza vaccination: an observational study. Eur Heart\u00a0J 44:610\u2013620. https:\/\/doi.org\/10.1093\/eurheartj\/ehac737","journal-title":"Eur Heart J"},{"key":"5291_CR16","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/ejhf.2945","volume":"25","author":"D Modin","year":"2023","unstructured":"Modin\u00a0D, Lassen\u00a0MCH, Claggett\u00a0B et\u00a0al (2023) Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A\u00a0meta-analysis. Eur J Heart Fail 25:1685\u20131692. https:\/\/doi.org\/10.1002\/ejhf.2945","journal-title":"Eur J Heart Fail"},{"key":"5291_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ahj.2022.10.005","volume":"255","author":"O Fr\u00f6bert","year":"2023","unstructured":"Fr\u00f6bert\u00a0O, G\u00f6tberg\u00a0M, Erlinge\u00a0D et\u00a0al (2023) Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction\u2014insights from the IAMI trial. Am Heart\u00a0J 255:82\u201389. https:\/\/doi.org\/10.1016\/j.ahj.2022.10.005","journal-title":"Am Heart J"},{"key":"5291_CR18","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/eurheartj\/ehr004","volume":"32","author":"A Phrommintikul","year":"2011","unstructured":"Phrommintikul\u00a0A, Kuanprasert\u00a0S, Wongcharoen\u00a0W et\u00a0al (2011) Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart\u00a0J 32:1730\u20131735. https:\/\/doi.org\/10.1093\/eurheartj\/ehr004","journal-title":"Eur Heart J"},{"key":"5291_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ehj.2003.10.018","volume":"25","author":"EP Gurfinkel","year":"2004","unstructured":"Gurfinkel\u00a0EP, de la Fuente\u00a0LR, Mendiz\u00a0O, Mautner\u00a0B (2004) Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart\u00a0J 25:25\u201331. https:\/\/doi.org\/10.1016\/j.ehj.2003.10.018","journal-title":"Eur Heart J"},{"key":"5291_CR20","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1161\/01.cir.0000016182.85461.f4","volume":"105","author":"EP Gurfinkel","year":"2002","unstructured":"Gurfinkel\u00a0EP, de la Fuente\u00a0RL, Mendiz\u00a0O, Mautner\u00a0B (2002) Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 105:2143\u20132147. https:\/\/doi.org\/10.1161\/01.cir.0000016182.85461.f4","journal-title":"Circulation"},{"key":"5291_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ejhf.2716","volume":"25","author":"A Peikert","year":"2023","unstructured":"Peikert\u00a0A, Claggett\u00a0BL, Kim\u00a0K et\u00a0al (2023) Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial. Eur J Heart Fail 25:299\u2013310. https:\/\/doi.org\/10.1002\/ejhf.2716","journal-title":"Eur J Heart Fail"},{"key":"5291_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/eurheartj\/ehac826","volume":"44","author":"O Fr\u00f6bert","year":"2023","unstructured":"Fr\u00f6bert\u00a0O, Cajander\u00a0S, Udell\u00a0JA (2023) The ideal vaccine to prevent cardiovascular disease. Eur Heart\u00a0J 44:621\u2013623. https:\/\/doi.org\/10.1093\/eurheartj\/ehac826","journal-title":"Eur Heart J"},{"key":"5291_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti\u00a0J, Wijns\u00a0W, Saraste\u00a0A et\u00a0al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart\u00a0J 41:407\u2013477. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"key":"5291_CR24","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne\u00a0RA, Rossello\u00a0X, Coughlan\u00a0JJ et\u00a0al (2023) 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart\u00a0J 44:3720\u20133826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"key":"5291_CR25","doi-asserted-by":"publisher","first-page":"e0207918","DOI":"10.1371\/journal.pone.0207918","volume":"13","author":"JY Song","year":"2018","unstructured":"Song\u00a0JY, Noh\u00a0JY, Lee\u00a0JS et\u00a0al (2018) Effectiveness of influenza and pneumococcal polysaccharide vaccines against influenza-related outcomes including pneumonia and acute exacerbation of cardiopulmonary diseases: Analysis by dominant viral subtype and vaccine matching. PLoS ONE 13:e207918. https:\/\/doi.org\/10.1371\/journal.pone.0207918","journal-title":"PLoS ONE"},{"key":"5291_CR26","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang\u00a0D, Hu\u00a0B, Hu\u00a0C et\u00a0al (2020) Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 323:1061\u20131069. https:\/\/doi.org\/10.1001\/jama.2020.1585","journal-title":"JAMA"},{"key":"5291_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijid.2020.07.038","volume":"99","author":"F Marra","year":"2020","unstructured":"Marra\u00a0F, Zhang\u00a0A, Gillman\u00a0E et\u00a0al (2020) The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A\u00a0systematic review and meta-analysis. Int J Infect Dis 99:204\u2013213. https:\/\/doi.org\/10.1016\/j.ijid.2020.07.038","journal-title":"Int J Infect Dis"},{"key":"5291_CR28","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1086\/656587","volume":"51","author":"IFN Hung","year":"2010","unstructured":"Hung\u00a0IFN, Leung\u00a0AYM, Chu\u00a0DWS et\u00a0al (2010) Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a\u00a0prospective cohort study. Int J Infect Dis 51:1007\u20131016. https:\/\/doi.org\/10.1086\/656587","journal-title":"Int J Infect Dis"},{"key":"5291_CR29","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1503\/cmaj.091891","volume":"182","author":"AN Siriwardena","year":"2010","unstructured":"Siriwardena\u00a0AN, Gwini\u00a0SM, Coupland\u00a0CAC (2010) Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ 182:1617\u20131623. https:\/\/doi.org\/10.1503\/cmaj.091891","journal-title":"CMAJ"},{"key":"5291_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/heartjnl-2021-319754","volume":"108","author":"FJ de Abajo","year":"2022","unstructured":"de Abajo\u00a0FJ, Rodr\u00edguez-Mart\u00edn\u00a0S, Barreira\u00a0D et\u00a0al (2022) Influenza vaccine and risk of acute myocardial infarction in a\u00a0population-based case-control study. Heart 108:1039\u20131045. https:\/\/doi.org\/10.1136\/heartjnl-2021-319754","journal-title":"Heart"},{"key":"5291_CR31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.hrthm.2016.01.026","volume":"13","author":"T-Y Chang","year":"2016","unstructured":"Chang\u00a0T\u2011Y, Chao\u00a0T\u2011F, Liu\u00a0C\u2011J et\u00a0al (2016) The association between influenza infection, vaccination, and atrial fibrillation: A\u00a0nationwide case-control study. Heart Rhythm 13:1189\u20131194. https:\/\/doi.org\/10.1016\/j.hrthm.2016.01.026","journal-title":"Heart Rhythm"},{"key":"5291_CR32","doi-asserted-by":"publisher","first-page":"e0219172","DOI":"10.1371\/journal.pone.0219172","volume":"14","author":"H-H Wu","year":"2019","unstructured":"Wu\u00a0H\u2011H, Chang\u00a0Y\u2011Y, Kuo\u00a0S\u2011C, Chen\u00a0Y\u2011T (2019) Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders\u2014A propensity score-matched follow-up study. PLoS ONE 14:e219172. https:\/\/doi.org\/10.1371\/journal.pone.0219172","journal-title":"PLoS ONE"},{"key":"5291_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jinf.2012.04.014","volume":"65","author":"Y-C Chang","year":"2012","unstructured":"Chang\u00a0Y\u2011C, Chou\u00a0Y\u2011J, Liu\u00a0J\u2011Y et\u00a0al (2012) Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75\u00a0years or older in Taiwan\u2014a representative population-based comparative study. J\u00a0Infect 65:231\u2013238. https:\/\/doi.org\/10.1016\/j.jinf.2012.04.014","journal-title":"J Infect"},{"key":"5291_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2017.07.020","volume":"193","author":"M-H Chiang","year":"2017","unstructured":"Chiang\u00a0M\u2011H, Wu\u00a0H\u2011H, Shih\u00a0C\u2011J et\u00a0al (2017) Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients. Am Heart\u00a0J 193:1\u20137. https:\/\/doi.org\/10.1016\/j.ahj.2017.07.020","journal-title":"Am Heart J"},{"key":"5291_CR35","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1056\/NEJM199409223311206","volume":"331","author":"KL Nichol","year":"1994","unstructured":"Nichol\u00a0KL, Margolis\u00a0KL, Wuorenma\u00a0J, Von Sternberg\u00a0T (1994) The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N\u00a0Engl J Med 331:778\u2013784. https:\/\/doi.org\/10.1056\/NEJM199409223311206","journal-title":"N Engl J Med"},{"key":"5291_CR36","first-page":"3","volume":"49","author":"T Rieck","year":"2022","unstructured":"Rieck\u00a0T, Steffen\u00a0A, Feig\u00a0M, Siedler\u00a0A (2022) Impfquoten bei Erwachsenen in Deutschland \u2013 Aktuelles aus der KV-Impfsurveillance. Epid Bull 49:3\u201323","journal-title":"Epid Bull"},{"key":"5291_CR37","doi-asserted-by":"publisher","first-page":"131654","DOI":"10.1016\/j.ijcard.2023.131654","volume":"399","author":"SR Monagle","year":"2024","unstructured":"Monagle\u00a0SR, Spear\u00a0E, Abrahams\u00a0T et\u00a0al (2024) Cardiologists\u2019 knowledge and perceptions of the seasonal influenza immunisation. Int J Cardiol 399:131654. https:\/\/doi.org\/10.1016\/j.ijcard.2023.131654","journal-title":"Int J Cardiol"},{"key":"5291_CR38","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1016\/s0264-410x(03)00296-2","volume":"21","author":"J Hedlund","year":"2003","unstructured":"Hedlund\u00a0J, Christenson\u00a0B, Lundbergh\u00a0P, Ortqvist\u00a0A (2003) Effects of a\u00a0large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a\u00a01-year follow-up. Vaccine 21:3906\u20133911. https:\/\/doi.org\/10.1016\/s0264-410x(03)00296-2","journal-title":"Vaccine"},{"key":"5291_CR39","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10654-020-00698-1","volume":"35","author":"AT Levin","year":"2020","unstructured":"Levin\u00a0AT, Hanage\u00a0WP, Owusu-Boaitey\u00a0N et\u00a0al (2020) Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol 35:1123\u20131138. https:\/\/doi.org\/10.1007\/s10654-020-00698-1","journal-title":"Eur J Epidemiol"},{"key":"5291_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40560-020-00508-6","volume":"8","author":"B-C Zhao","year":"2020","unstructured":"Zhao\u00a0B\u2011C, Liu\u00a0W\u2011F, Lei\u00a0S\u2011H et\u00a0al (2020) Prevalence and prognostic value of elevated troponins in patients hospitalised for coronavirus disease 2019: a\u00a0systematic review and meta-analysis. j intensive care 8:88. https:\/\/doi.org\/10.1186\/s40560-020-00508-6","journal-title":"j intensive care"},{"key":"5291_CR41","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.22037\/aaem.v9i1.1071","volume":"9","author":"A Toloui","year":"2021","unstructured":"Toloui\u00a0A, Moshrefiaraghi\u00a0D, Madani Neishaboori\u00a0A et\u00a0al (2021) Cardiac Complications and Pertaining Mortality Rate in COVID-19\u00a0Patients; a\u00a0Systematic Review and Meta-Analysis. Arch Acad Emerg Med 9:e18. https:\/\/doi.org\/10.22037\/aaem.v9i1.1071","journal-title":"Arch Acad Emerg Med"},{"key":"5291_CR42","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jacc.2022.12.006","volume":"81","author":"J Jiang","year":"2023","unstructured":"Jiang\u00a0J, Chan\u00a0L, Kauffman\u00a0J et\u00a0al (2023) Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection. J\u00a0Am Coll Cardiol 81:928\u2013930. https:\/\/doi.org\/10.1016\/j.jacc.2022.12.006","journal-title":"J Am Coll Cardiol"},{"key":"5291_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/jama.2022.12992","volume":"328","author":"Y-E Kim","year":"2022","unstructured":"Kim\u00a0Y\u2011E, Huh\u00a0K, Park\u00a0Y\u2011J et\u00a0al (2022) Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection. JAMA 328:887\u2013889. https:\/\/doi.org\/10.1001\/jama.2022.12992","journal-title":"JAMA"},{"key":"5291_CR44","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1164\/ajrccm.160.3.9901004","volume":"160","author":"EE Walsh","year":"1999","unstructured":"Walsh\u00a0EE, Falsey\u00a0AR, Hennessey\u00a0PA (1999) Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med 160:791\u2013795. https:\/\/doi.org\/10.1164\/ajrccm.160.3.9901004","journal-title":"Am J Respir Crit Care Med"},{"key":"5291_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1186\/s12879-014-0665-2","volume":"14","author":"C Volling","year":"2014","unstructured":"Volling\u00a0C, Hassan\u00a0K, Mazzulli\u00a0T et\u00a0al (2014) Respiratory syncytial virus infection-associated hospitalization in adults: a\u00a0retrospective cohort study. BMC Infect Dis 14:665. https:\/\/doi.org\/10.1186\/s12879-014-0665-2","journal-title":"BMC Infect Dis"},{"key":"5291_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cmi.2016.11.014","volume":"23","author":"P Loubet","year":"2017","unstructured":"Loubet\u00a0P, Lenzi\u00a0N, Valette\u00a0M et\u00a0al (2017) Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France. Clin Microbiol Infect 23:253\u2013259. https:\/\/doi.org\/10.1016\/j.cmi.2016.11.014","journal-title":"Clin Microbiol Infect"},{"key":"5291_CR47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2209604","volume":"388","author":"A Papi","year":"2023","unstructured":"Papi\u00a0A, Ison\u00a0MG, Langley\u00a0JM et\u00a0al (2023) Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults. N\u00a0Engl J Med 388:595\u2013608. https:\/\/doi.org\/10.1056\/NEJMoa2209604","journal-title":"N Engl J Med"},{"key":"5291_CR48","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","volume":"388","author":"EE Walsh","year":"2023","unstructured":"Walsh\u00a0EE, Marc\u00a0GP, Zareba\u00a0AM et\u00a0al (2023) Efficacy and Safety of a\u00a0Bivalent RSV Prefusion F Vaccine in Older Adults. N\u00a0Engl J Med 388:1465\u20131477. https:\/\/doi.org\/10.1056\/NEJMoa2213836","journal-title":"N Engl J Med"},{"key":"5291_CR49","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","volume":"389","author":"E Wilson","year":"2023","unstructured":"Wilson\u00a0E, Goswami\u00a0J, Baqui\u00a0AH et\u00a0al (2023) Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults. N\u00a0Engl J Med 389:2233\u20132244. https:\/\/doi.org\/10.1056\/NEJMoa2307079","journal-title":"N Engl J Med"},{"key":"5291_CR50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/vaccines12030252","volume":"12","author":"M Yamaoka-Tojo","year":"2024","unstructured":"Yamaoka-Tojo\u00a0M, Tojo\u00a0T (2024) Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination. Vaccines 12:252. https:\/\/doi.org\/10.3390\/vaccines12030252","journal-title":"Vaccines"},{"key":"5291_CR51","doi-asserted-by":"publisher","first-page":"ofad137","DOI":"10.1093\/ofid\/ofad137","volume":"10","author":"GI Parameswaran","year":"2023","unstructured":"Parameswaran\u00a0GI, Drye\u00a0AF, Wattengel\u00a0BA et\u00a0al (2023) Increased Myocardial Infarction Risk Following Herpes Zoster Infection. Open Forum Infect Dis 10:ofad137. https:\/\/doi.org\/10.1093\/ofid\/ofad137","journal-title":"Open Forum Infect Dis"},{"key":"5291_CR52","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2017.03.014","volume":"308","author":"MA Nagel","year":"2017","unstructured":"Nagel\u00a0MA, Jones\u00a0D, Wyborny\u00a0A (2017) Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis. J\u00a0Neuroimmunol 308:112\u2013117. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.03.014","journal-title":"J Neuroimmunol"},{"key":"5291_CR53","doi-asserted-by":"publisher","first-page":"e027451","DOI":"10.1161\/JAHA.122.027451","volume":"11","author":"SG Curhan","year":"2022","unstructured":"Curhan\u00a0SG, Kawai\u00a0K, Yawn\u00a0B et\u00a0al (2022) Herpes Zoster and Long-Term Risk of Cardiovascular Disease. J\u00a0Am Heart Assoc 11:e27451. https:\/\/doi.org\/10.1161\/JAHA.122.027451","journal-title":"J Am Heart Assoc"},{"key":"5291_CR54","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/1346-8138.14597","volume":"45","author":"H-M Seo","year":"2018","unstructured":"Seo\u00a0H\u2011M, Cha\u00a0M\u2011J, Han\u00a0JH et\u00a0al (2018) Reciprocal relationship between herpes zoster and cardiovascular diseases: A\u00a0nationwide population-based case\u2013control study in Korea. J\u00a0Dermatol 45:1312\u20131318. https:\/\/doi.org\/10.1111\/1346-8138.14597","journal-title":"J Dermatol"},{"key":"5291_CR55","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/infdis\/jit405","volume":"208","author":"S Weinmann","year":"2013","unstructured":"Weinmann\u00a0S, Chun\u00a0C, Schmid\u00a0DS et\u00a0al (2013) Incidence and Clinical Characteristics of Herpes Zoster Among Children in the Varicella Vaccine Era, 2005\u20132009. J\u00a0Infect Dis 208:1859\u20131868. https:\/\/doi.org\/10.1093\/infdis\/jit405","journal-title":"J Infect Dis"},{"key":"5291_CR56","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.36849\/JDD.7415","volume":"22","author":"MF Helm","year":"2023","unstructured":"Helm\u00a0MF, Khoury\u00a0PA, Pakchanian\u00a0H et\u00a0al (2023) Recombinant Zoster Vaccine Reduces 3\u2011Year Cardiovascular Risk: Insights From a\u00a0Multi-Centered Database. J\u00a0Drugs Dermatol 22:1178\u20131182. https:\/\/doi.org\/10.36849\/JDD.7415","journal-title":"J Drugs Dermatol"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-024-05291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-024-05291-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-024-05291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T09:10:51Z","timestamp":1743325851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-024-05291-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5291"],"URL":"https:\/\/doi.org\/10.1007\/s00059-024-05291-w","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"type":"print","value":"0340-9937"},{"type":"electronic","value":"1615-6692"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"12 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"M.\u00a0B\u00f6hm gibt an, Vortragshonorare erhalten zu haben von Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Cytokinetics, Edwards, Medtronic, Novartis, ReCor, Servier, Vifor und GSK. T\u00e4tigkeit im Advisory Board von Amgen, Bayer, Boehringer Ingelheim, Cytokinetics, Edwards, Medtronic, Novartis, Pfizer, ReCor, Servier, Vifor. Forschungsunterst\u00fctzung erhalten von Deutsche Forschungsgemeinschaft (German Research Foundation [DFG]; SFB-TTR 219). M.\u00a0Therre, M.\u00a0Tokcan und P.\u00a0Markwirth geben an, dass kein Interessenkonflikt besteht.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}